News
The aldosterone test determines the levels of a hormone called aldosterone in your blood. Learn more about the procedure & how its linked to blood pressure & adrenal gland disorders.
Hyperaldosteronism is when your adrenal glands make too much aldosterone hormone. Learn about the causes, symptoms, and treatment options for this condition today.
A comparison of aldosterone concentrations in blood from the right and left adrenal veins might be expected to confirm the presence and location of a unilateral aldosterone-producing adenoma.
Aldosterone, a hormone made by the adrenal glands, has been linked to kidney disease in people with diabetes, and now in those without it. Skip to Main Content. research. Cancer. racism.
THE secretion of aldosterone differs from that of other steroids of the adrenal cortex in that it is not directly under pituitary control. Current concepts favour a location in the diencephalon ...
Aldosterone is associated with an increased risk of chronic kidney disease progression and the development of end-stage kidney disease, according to data published in the European Heart Journal ...
Hyperaldosteronism is when one or both adrenal glands release too much of the hormone aldosterone. High blood pressure can result, which could lead to atrial fibrillation, heart attack, or stroke ...
Researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas -- adrenal gland tumors that drive high blood pressure. Using cutting-edge analysis techniques, they ...
An op-ed published in February by Tom Frieden, MD, MPH, former director of the CDC, described hypertension as “the deadliest but most neglected and widespread pandemic of our time” — and ...
Lorundrostat, a novel therapy which blocks the production of aldosterone from the adrenal glands, demonstrated clinically meaningful and sustained reductions in blood pressure in 1,083 patients ...
Lorundrostat showed significant efficacy when dose groups were combined for an analysis of placebo-adjusted change in 24-hour average systolic BP at week 4 (-5.3 mm Hg, 95% CI -8.4 to -2.3 ...
Purpose: The clinical benefits, adverse effects, pharmacokinetics, and recommendations for the appropriate use of the aldosterone antagonists spironolactone and eplerenone in patients with heart ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results